Cargando…

Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy

Sarcopenia is associated with low muscle mass and low physical performance. Here, we performed to evaluate the sarcopenia as prognostic factor and treatment outcomes in older patients with locally advanced rectal cancer (LARC) who received preoperative or postoperative chemoradiotherapy (CRT). LARC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Song Ee, Hwang, In Gyu, Choi, Chang Hwan, Kang, Hyun, Kim, Beom Gyu, Park, Byung Kwan, Cha, Seong Jae, Jang, Joung-Soon, Choi, Jin Hwa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283099/ https://www.ncbi.nlm.nih.gov/pubmed/30508928 http://dx.doi.org/10.1097/MD.0000000000013363

Ejemplares similares

Additional Chemotherapy with 5-FU plus Leucovorin between Preoperative Chemoradiotherapy and Surgery Improved Treatment Outcomes in Patients with Advanced Rectal Cancer
por: Park, Song Ee, et al.
Publicado: (2019)

Effect of leukocyte alteration on treatment outcomes following preoperative chemoradiotherapy in patients with rectal cancer
por: Kim, Tae Gyu, et al.
Publicado: (2017)

Predicting multi-class responses to preoperative chemoradiotherapy in rectal cancer patients
por: Gim, Jungsoo, et al.
Publicado: (2016)

Matched case-control analysis comparing oncologic outcomes between preoperative and postoperative chemoradiotherapy for rectal cancer
por: Lee, Byoung Chul, et al.
Publicado: (2017)

Predictors of pathologic complete response after preoperative concurrent chemoradiotherapy of rectal cancer: a single center experience
por: Choi, Euncheol, et al.
Publicado: (2016)

Simultaneous integrated boost intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy in preoperative concurrent chemoradiotherapy for locally advanced rectal cancer
por: Bae, Bong Kyung, et al.
Publicado: (2017)

Comparison between preoperative and postoperative concurrent chemoradiotherapy for rectal cancer: an institutional analysis
por: Lee, Jeong Won, et al.
Publicado: (2013)

Clinical Significance of Tumor Regression Grade in Rectal Cancer with Preoperative Chemoradiotherapy
por: Park, Young Joo, et al.
Publicado: (2010)

Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancer
por: Choi, Chi Hwan, et al.
Publicado: (2012)

Is Preoperative Chemoradiotherapy Beneficial for Sphincter Preservation in Low-Lying Rectal Cancer Patients?
por: Park, In Ja, et al.
Publicado: (2016)

Beware of Early Relapse in Rectal Cancer Patients Treated With Preoperative Chemoradiotherapy
por: Oh, Seul Gi, et al.
Publicado: (2020)

Short-term outcomes after laparoscopic surgery following preoperative chemoradiotherapy for rectal cancer
por: Ahn, Byong Hyon, et al.
Publicado: (2012)

PCSK1 Overexpression in Rectal Cancer Correlates with Poor Response to Preoperative Chemoradiotherapy and Prognosis
por: Chou, Chia-Lin, et al.
Publicado: (2020)

Preoperative chemoradiotherapy followed by local excision in clinical T2N0 rectal cancer
por: Shin, Young Seob, et al.
Publicado: (2016)

Does total regression of primary rectal cancer after preoperative chemoradiotherapy represent “no tumor” status?
por: Jeong, Seong-A, et al.
Publicado: (2019)

Efficacy of preoperative chemoradiotherapy in patients with cT2N0 distal rectal cancer
por: Park, Min Young, et al.
Publicado: (2023)

Surgical issues in locally advanced rectal cancer treated by preoperative chemoradiotherapy
por: Lim, Seok-Byung, et al.
Publicado: (2013)

Influence of Preoperative Chemoradiotherapy on the Surgical Strategy According to the Clinical T Stage of Patients With Rectal Cancer
por: Park, In Ja, et al.
Publicado: (2015)

Correlation between T stage and lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy
por: Kim, Seijong, et al.
Publicado: (2022)

Efficacy of hypofractionated preoperative chemoradiotherapy in rectal cancer
por: Cho, Ick Joon, et al.
Publicado: (2023)

Utility of RGNEF in the Prediction of Clinical Prognosis in Patients with Rectal Cancer Receiving Preoperative Concurrent Chemoradiotherapy
por: Chen, Chih-I., et al.
Publicado: (2021)

A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer
por: Jo, Hyunji, et al.
Publicado: (2023)

Clinical Outcomes of Local Excision Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Lee, Nam Kwon, et al.
Publicado: (2014)

Long-term outcomes of surgery alone versus surgery following preoperative chemoradiotherapy for early T3 rectal cancer: A propensity score analysis
por: Cho, Seung Hyun, et al.
Publicado: (2017)

Oncologic Outcomes of Organ Preserving Approaches in Patients With Rectal Cancer Treated With Preoperative Chemoradiotherapy
por: Park, In Ja, et al.
Publicado: (2019)

Prognostic Significance of Tumor Regression Grade after Preoperative Chemoradiotherapy for Rectal Cancer
por: Kim, Byung Chun
Publicado: (2011)

Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy
por: Xu, Ying-Ying, et al.
Publicado: (2021)

Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy
por: Sung, SooYoon, et al.
Publicado: (2017)

Early Systemic Failure After Preoperative Chemoradiotherapy for the Treatment of Patients With Rectal Cancer
por: Choi, Taesun, et al.
Publicado: (2019)

Loss of skeletal muscle mass during palliative chemotherapy is a poor prognostic factor in patients with advanced gastric cancer
por: Park, Song Ee, et al.
Publicado: (2020)

Malnutrition in rectal cancer patients receiving preoperative chemoradiotherapy is common and associated with treatment tolerability and anastomotic leakage
por: Yamano, Tomoki, et al.
Publicado: (2016)

What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?
por: Kim, Soo Hee, et al.
Publicado: (2016)

A review of preoperative chemoradiotherapy for lower rectal cancer
por: Beppu, Naohito, et al.
Publicado: (2018)

Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II–III resectable rectal cancer: a meta-analysis of randomized controlled trials
por: Song, Jin Ho, et al.
Publicado: (2017)

Is the pathological regression level of metastatic lymph nodes associated with oncologic outcomes following preoperative chemoradiotherapy in rectal cancer?
por: Choi, Jung Pil, et al.
Publicado: (2017)

Commentary: Association of Sarcopenia with Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy
por: Bahat, Zumrut, et al.
Publicado: (2022)

Peri-treatment change of anorectal function in patients with rectal cancer after preoperative chemoradiotherapy
por: Song, Jin Sook, et al.
Publicado: (2017)

Preoperative Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer: Treatment Outcomes and Analysis of Prognostic Factors
por: Kong, Moonkyoo, et al.
Publicado: (2012)

Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy
por: Jeon, Ye Won, et al.
Publicado: (2021)

Genetic polymorphisms in genes regulating cell death and prognosis of patients with rectal cancer receiving postoperative chemoradiotherapy
por: Chen, Hongxia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oopu46i3sv8h11hgt8m7s1257n